Drugs likely to cost more after hike in excise duty

Drugs are expected to cost more following an increase in excise duty to 6 per cent from 5 per cent on formulations and to 12 per cent from 10 per cent on bulk drugs announced by ...

French devicemaker Carmat SAS readies artificial heart for human trial

By Mark Hollmer French medical device maker Carmat SAS is ready to begin testing its new artificial heart in human patients and awaits final regulatory OK to pull the trigger ...

Gilead-Medivir Hepatitis C Drug Clears Virus in Patients

By Ryan Flinn & Shannon Pettypiece An experimental drug combination from Gilead Sciences Inc. (GILD), Medivir AB (MVIRB) andJohnson & Johnson (JNJ) eradicated the virus ...

FDA echoes questions over Intuitive’s surgical robot

By Damian Garde Last week, a large-scale study in the Journal of the American Medical Association concluded that Intuitive Surgical’s ($ISRG) robot does little more than up ...

CardioKinetix will use $23M round to propel EU heart failure device launch

The Series E second tranche will also back a massive U.S. trial and other related projects By Mark Hollmer In the fall of 2011, CardioKinetix raised the first half of its $44 million ...

Sequester Expected to Have Big Impact on Food Safety; Details Unknown

Taylor: Reducing funding at FDA “wrong direction” BY HELENA BOTTEMILLER Other than a memo put out by the White House earlier this month, which forecast reduced food inspections ...

FDA Denies Reckitt Petition Over Generic Suboxone

By Ed Silverman In a huge blow to Reckitt Benckiser, the FDA late last week rejected a citizen petition the company had filed last fall in hopes of thwarting generic rivals to its best-selling ...

Updated: TearScience wins $70M funding commitment for dry eye device

By Mark Hollmer TearScience will tap up to a whopping $70 million in new financing to ramp up commercial marketing efforts for its dry eye treatment device. HealthCare Royalty Partners ...

USPSTF recommends against postmenopausal vitamin D/calcium supplementation

By SHARON WORCESTER The U.S. Preventive Services Task Force has recommended against vitamin D and calcium supplementation in healthy postmenopausal women, citing research showing that ...

Biotronik nabs FDA nod for single-lead ICD

By Damian Garde Biotronik got the FDA‘s final approval on Lumax 740 DX, a first-in-class single-lead ICD designed to treat atrial fibrillation that the company says could ...

NeuroPace wins FDA panel vote for epilepsy implant

By Damian Garde NeuroPace is on the path to FDA approval for its anti-epilepsy neurostimulation device, winning unanimous backing from the agency’s neurological devices ...

Former Peanut Firm Executives Indicted Over 2009 Salmonella Outbreak

By DAN CHARLES Four former executives from Peanut Corp. of America and a related company are facing federal criminal charges for covering up information that their peanut butter was ...
Page 3 of 2212345...1020...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS